Notes

$UBER under accumulation off the 2021 highs? Sure looks like it. 👀
$UBER
FTC sues Uber, $UBER, says company charged for Uber One without consent
$UBER
$UBER: KGI Securities Downgrades to Neutral from Outperform - PT $78 $UBER: Fox Advisors Downgrades to Equalweight from Overweight
$UBER
MORNING BID 🔸 QXO ( $QXO) is in talks to buy Beacon Roofing Supply (BECN) for $11B ($124.35/share in cash). 🔸 Uber ( $UBER) & Lyft ( $LYFT) dominate North American ride-hailing, but Bolt aims to challenge them, per The Information. 🔸 Xpeng ( $XPEV) plans to mass-produce its modular flying car by 2026, said Chairman He Xiaopeng. 🔸 Yum China ( $YUM) appointed Adrian Ding as CFO, removing his interim title after a search following Andy Yeung’s resignation. 🔸 Franco-Nevada ( $FNV) Q4 adj. EPS $0.95 (est. $0.89), revenue $321M (+6% y/y, est. $304.44M); expects 2025 revenue to rise 25%+ with gold at $2,800/oz. Upgrades: 🔸 Grainger ( $GWW), Fastenal (FAST) → Outperform (from Market Perform) at William Blair. 🔸 Knight-Swift ( $KNX) → Neutral (from Sell) at Citigroup. Downgrade: 🔸 Sherwin-Williams ( $SHW) → Hold (from Buy) at Jefferies. 🔸 Beam Therapeutics ( $BEAM) prices 16.2M shares at $28.48 each. 🔸 DexCom ( $DXCM) gets FDA warning after inspections but sees no material impact on FY25 revenue. 🔸 Nordisk ( $NVO) reports REDEFINE 2 trial met its primary endpoint, showing significant weight loss with CagriSema in 1,206 patients over 68 weeks. 🔸 Trevi ( $TRVI) Phase 2a RIVER trial: Haduvio reduced 24-hour cough frequency by 67% (57% placebo-adjusted, p<0.0001). 🔸 Cognizant ( $CTSH) shares rose as Mantle Ridge built a $1B+ stake, seeing them as undervalued (WSJ). Upgrades: 🔸 DocuSign ( $DOCU) → Neutral (from Underweight) at JPMorgan. Deals: 🔸 NVent ( $NVT) to buy Avail’s electrical products for $975M, expects EPS boost in year one. 🔸 Perion ( $PERI) expands buyback program to $125M. 🔸 Taiwan Semi ( $TSM) Feb revenue NT$260.01B (+43% y/y, -11% m/m); Jan-Feb total NT$553.30B (+39% y/y).
$QXO $UBER $LYFT $XPEV $YUM $FNV $GWW $KNX $SHW $BEAM
+1.22%
$DXCM $NVO $TRVI $CTSH $DOCU $NVT $PERI $TSM
-8.8%
$GOOGL $UBER - UBER: NOW LAUNCHING AUTONOMOUS WAYMO RIDES IN AUSTIN; TO OFFER WAYMO RIDES IN ATLANTA SOON
$GOOGL $UBER
$UBER and $TM 13Fs show a combined ownership of 20% of the outstanding $GRAB ADR shares
$UBER $TM $GRAB
+0.54%
BREAKING: Steven Cohen (Point72) updated their portfolio. As soon as his filing comes in, we update the full positions and portfolios on Unusual Whales. Get it live and first! Cohen increased $MSFT, $NVDA, $TSM, $UBER, $MSTR (call options!!), new in $SPHR.
$MSFT
-12.08%
$NVDA
+5.46%
$TSM
-8.8%
$UBER $MSTR
-99.97%
$SPHR
Discounted @unusual_whales subscriptions available through February 17 with the #ValentinesDay Sale — this $UBER trade paid for the annual subscription with just one contract ✅📝😎
$UBER
Check this. Bill Ackman invested $2.3 Billion in $UBER. Did someone know? Maybe. $UBER had its highest net premiums yesterday over the last 30 days. What's more, the top chains yesterday were shorting the $55 put, buying the 0DTE $68, $70 calls!!! Those trades closed this
$UBER
$UBER 2 days of strong bullish call flow
$UBER
Let’s break down this @unusual_whales flow alert and incredibly profitable trade idea on $UBER that came in on Thursday following earnings on Wednesday and ahead of the Bill Ackman news disclosing his 30M share stake The $77.50 calls for January came in as a sweep on Thursday
$UBER
Good morning to everyone:
$UBER
Good night to everyone:
$UBER
Check this. Bill Ackman invested $2.3 Billion in $UBER. Did someone know? Maybe. $UBER had its highest net premiums yesterday over the last 30 days. What's more, the top chains yesterday were shorting the $55 put, buying the 0DTE $68, $70 calls!!! Those trades closed this morning for millions as $UBER went 7%. Unusual.
$UBER
Bill Ackman has built a position in $UBER worth $2.3 billion
$UBER
$UBER - BILL ACKMAN: WE OWN 33.3 MILLION SHARES IN UBER - X POST
$UBER
$UBER Calls are active for March, April and June expiration. Nice bounce from ER drop. @unusual_whales
$UBER
$Uber Q4 Results Summary: 🔸 Gross Bookings: $44.20B, +18% y/y. 🔸 Mobility: $22.80B, +18% (est. $22.52B). 🔸 Delivery: $20.13B, +18% (est. $19.7B). 🔸 Freight: $1.27B, -0.5% (est. $1.31B). 🔸 Revenue: $11.96B, +20% (est. $11.77B). 🔸 Adj. EBITDA: $1.84B, +44% (est. $1.85B). 🔸 EPS: $3.21 (vs. $0.66 y/y). 🔸 Trips: 3.07B, +18% (est. 3.02B). 🔸 Net Income: $6.88B (vs. $1.43B y/y). 🔸 Monthly Active Users: 171M, +14% (est. 168.35M). 🔸 Stock-Based Compensation: $419M, -11% (est. $463.5M). Q1 Guidance: 🔸 Gross Bookings: $42B - $43.5B. 🔸 Adj. EBITDA: $1.79B - $1.89B (est. $1.84B).
$Uber
$UBER $GOOGL - UBER: TO LAUNCH WAYMO ROBOTAXIS EXCLUSIVELY ON UBER APP IN AUSTIN
$UBER $GOOGL
$UBER - Uber Announces $1.5 Billion Accelerated Share Repurchase Program
$UBER
$TSLA $GOOGL $UBER $LYFT - UBER, LYFT EMBRACE ROBOTAXI COMPETITION -- WSJ The ride-hailing leaders are preparing to bring driverless taxis to your door with new app features that allow customers to use their phones to open trunks and honk horns. They are building infrastructure to maintain the high-tech taxis and training human support staff to handle riders without drivers. Both companies will have driverless cars -- from Alphabet's Waymo and others
$TSLA
-16.31%
$GOOGL $UBER $LYFT
MORNING RECAP • Target Corp. ( $TGT): Shares fell after Q3 results missed expectations; EPS $1.85 vs. $2.30 est., sales up 0.9% to $25.23B missing $25.74B est., and operating margin at 4.6% vs. 5.6% est. FY EPS guidance lowered to $8.30-$8.90 from $9-$9.70. • Azek Company ( $AZEK): Beat Q4 expectations with EPS at $0.29 vs. $0.27 est., adjusted EBITDA $91.8M vs. $88.1M, and sales at $348.22M. FY25 guidance: revenue $1.51B-$1.54B, adjusted EBITDA $400M-$415M. • Chewy ( $CHWY): Upgraded to 'Buy' by Bank America with price target raised to $40 from $24. • Delta Air Lines ( $DAL): Projects mid-single digit revenue growth for 2025, with capacity expansion up to 4%. • La-Z-Boy ( $LZB): Q2 EPS $0.71 vs. $0.64 est., sales up 1.9% to $521M, Q3 guidance provided, dividend raised to $0.22. • Uber ( $UBER): Launched Uber XXL for airport travel in 60+ airports and new reservation features with flight tracking. • AeroVironment ( $AVAV): Upgraded to Buy from Hold by Jefferies. • DT Midstream ( $DTM): Acquires three pipelines from Oneok for $1.2B, spanning 1,300 miles across seven Midwest states. • Dycom ( $DY): Q3 EPS $2.68 vs. $2.26 est., revenue $1.27B vs. $1.22B est.; anticipates mid- to high single-digit revenue growth in Q4. • Patrick Industries ( $PATK): Announces a 3-for-2 stock split. • Powell Industries ( $POWL): Q4 revenue up 32.1% to $275.1M, but missed $284.3M est.; EPS $3.77 vs. $3.55 est.; orders up 56% to $267M, backlog steady at $1.3B, expects strong FY25. • SolarEdge ( $SEDG): Upgraded to Neutral from Sell by Guggenheim, previous $10 price target dropped. • Forestar Group ( $FOR): Files for potential sale of up to $300M in common stock. • JPMorgan ( $JPM): Downgraded to Perform from Outperform by Oppenheimer due to valuation. • Lemonade ( $LMND): Upgraded to equal weight from underweight by Morgan Stanley post-investor day. • StoneX Group ( $SNEX): Q4 EPS $2.32 vs $2.05 est., net revenue $454.8M vs $462.98M est. • XP Inc. ( $XP): Launches a buyback program up to R$1.0B; Q3 EPS as expected at 2.18, revenue slightly below at 4.319B; active clients increased to 4.7M. • Concentra Group Holdings Inc. ( $CON) will replace Myers Industries Inc. (MYE) in the S&P SmallCap 600 on November 27, following a distribution by Select Medical Holdings Corp. (SEM). • Pfizer ( $PFE) appointed Chris Boshoff as its R&D chief starting January 1. It also received EC approval for Hympavzi for hemophilia treatment. • Sangamo Therapeutics ( $SGMO) received FDA clearance for ST-503 human trials, with enrollment planned for mid-2025. • Varex Imaging ( $VREX) reported Q4 EPS at $0.19, beating the $0.09 estimate, but revenue dropped 10% to $205.7M. Forecasts Q1 revenue between $195M-$215M. • Viking Therapeutics ( $VKTX) shared positive mid-stage trial results for VK2809, showing significant improvement in liver fibrosis over placebo. • Comcast Corp. ( $CMCSA) is set to spin off cable channels like MSNBC, CNBC, and USA to reduce exposure to declining viewership and ad revenue, keeping NBC and Peacock, per WSJ. • Dolby Labs ( $DLB) Q4 EPS $0.81 vs. $0.70 est., revenue slightly below at $305M. Forecasts Q1 revenue $330-360M and FY revenue $1.33-1.39B. • Flex Ltd ( $FLEX) will replace Azenta Inc. ( $AZTA) in S&P MidCap 400, with Azenta moving to S&P SmallCap 600, effective November 25. • Keysight Technologies (KEYS) Q4 EPS $1.65 vs. $1.57 est., revenue at $1.287B. Q1 guidance: revenue $1.265-1.285B, EPS $1.65-1.71. • https://t.co/jK5z8CZLV2 ( $WIX) Q3 EPS $1.62 vs. $1.51 est., revenue $444.67M vs. $457.9M est. Increases FY24 revenue and bookings forecasts. • ZoomInfo Technologies ( $ZI) Chairman Schuck purchased 492,500 shares at $10.25 each on November 15, transaction worth $5,049,750.
$TGT $AZEK $CHWY
+15.63%
$DAL $LZB $UBER $AVAV $DTM $DY $PATK $POWL $SEDG $FOR
+7.27%
$JPM $LMND $SNEX $XP
-0.09%
$CON $PFE $SGMO $VREX $VKTX $CMCSA $DLB $FLEX $AZTA $WIX $ZI
Stock Gainers Brief: • $CVS: +3%; added four new board members, including Larry Robbins from Glenview Capital, expanding to 16 members; upgraded by Wells Fargo. • $FOUR: +4%; to join S&P MidCap 400 in place of RCM on November 20. • $HOOD: +6%; upgraded to Buy by Needham due to expected benefits from Trump's policy changes at SEC. • $LBRT: +2%; stock up with Chris Wright, a fracking advocate, nominated for Energy Secretary. • $MBI: +10%; upgraded to Outperform by KBW with a new $9 target after favorable legal and earnings news. • $SMCI: +9%; plans to meet Nasdaq compliance requirements for continued listing. • $TSLA: +8%; due to Trump team's interest in autonomous vehicle regulations. • $WOLF: +5%; CEO Gregg Lowe ousted, Thomas Werner steps in as Executive Chairman during CEO search. Stock Laggards Brief: • $BIIB: -1%; downgraded to Hold by Needham, with no expected upside in the next year. • $CMAX: -55%; filed for bankruptcy with $693M in debt, $390M in assets. • $LLY: -4%; continues to decline with other obesity/healthcare stocks. • $MARA: -6%; issuing $700M in convertible notes. • $NGNE: -35%; halted development of high-dose gene therapy due to serious side effect. • $PLTR: -9%; despite being a top S&P performer YTD, sees significant drop. • $UBER & $LYFT: -6%; both affected by news of potential regulations for autonomous vehicles.
$CVS $FOUR
+1.09%
$HOOD
+2.78%
$LBRT $MBI $SMCI $TSLA
-16.31%
$WOLF
+19.85%
$BIIB $CMAX $LLY $MARA $NGNE $PLTR $UBER $LYFT
$UBER $LYFT - UBER, LYFT SHARES DOWN AS MUSK SAYS TESLA TO ROLL OUT RIDE-HAILING IN TEXAS AND CALIFORNIA NEXT YEAR UBER DOWN 2.5%, LYFT DOWN 1.9%
$UBER $LYFT
$UBER - UBER SHARES DOWN 2%, REPORT SAYS CO EXPLORED POSSIBLE BID FOR EXPEDIA
$UBER
$UBER - UBER EXPLORED POSSIBLE BID FOR EXPEDIA IN ‘SUPER APP’ GROWTH PUSH - FT
$UBER
$UBER - Uber Starts $18 Shuttle Service Between Manhattan and LaGuardia Airport, Company Says -- WSJ Uber Routes Go Between Port Authority, Grand Central, Penn Station and LaGuardia -- WSJ Uber Plans to Expand to Other Airports, Company Says -- WSJ
$UBER
UBER AND WAYMO EXPAND PARTNERSHIP TO BRING AUTONOMOUS RIDE-HAILING TO AUSTIN AND ATLANTA $UBER $GOOGL
$UBER $GOOGL
$UBER UBER KICKS OFF ITS FIRST BOND SALE AS INVESTMENT-GRADE COMPANY
$UBER
⚡UBER HIRES FORMER TESLA CHARGING CHIEF REBECCA TINUCCI FOR EV EFFORTS - SPOKESMAN $UBER
$UBER
NYC TAXI REGULATOR AGREES NOT TO IMPOSE NEW RULES ON $UBER, $LYFT
$UBER $LYFT
Sign in to Coinnx